MarketPeel
Insider Trading Intelligence
Pricing
…
WY

Weiguo Ye

GYRE
CHIEF OPERATING OFFICER · GYRE THERAPEUTICS, INC. · CIK 0001985496
FILING MIX · LIFETIME38%/62%
BUYS
22
SELLS
36
TOTAL VALUE
$1.50M
COMPANIES
1
ACTIVE SINCE
Nov 2023
HOLDINGS NOW
703,000
AVG SELL PX
$6.33
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Weiguo Ye. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
GYRE · 703,000 shares · as of Jun 18, 2026
0416,279832,5581,248,8361,665,115202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 22 buys / 36 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
3,000$0.75$2.3K703,000Jun 18, 2026Jun 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,000——827,701Jun 18, 2026Jun 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,000$6.35$19.1K700,000Jun 18, 2026Jun 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,800$0.75$2.1K702,800Jun 11, 2026Jun 15, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,800——838,701Jun 11, 2026Jun 15, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,800$6.17$17.3K700,000Jun 11, 2026Jun 15, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
6,418$0.75$4.8K706,418Jun 10, 2026Jun 11, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
6,418——841,501Jun 10, 2026Jun 11, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
6,418$6.21$39.9K700,000Jun 10, 2026Jun 11, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
5,000——830,701Jun 10, 2026Jun 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
5,000$0.75$3.8K705,000Jun 10, 2026Jun 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
5,000$6.24$31.2K700,000Jun 10, 2026Jun 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
14,500——847,919Jun 9, 2026Jun 11, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
14,500$0.75$10.9K714,500Jun 9, 2026Jun 11, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
14,500$6.14$89.0K700,000Jun 9, 2026Jun 11, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,000$6.15$18.4K700,000Jun 9, 2026Jun 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,000——835,701Jun 9, 2026Jun 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
3,000$0.75$2.3K703,000Jun 9, 2026Jun 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
15,401$0.75$11.6K715,401Jun 5, 2026Jun 8, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
15,401——862,419Jun 5, 2026Jun 8, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
15,401$6.40$98.6K700,000Jun 5, 2026Jun 8, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
19,575$0.75$14.7K719,575Jun 4, 2026Jun 8, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
19,575——877,820Jun 4, 2026Jun 8, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
19,575$6.13$120.0K700,000Jun 4, 2026Jun 8, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
4,000$6.10$24.4K700,000May 26, 2026May 27, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
4,000$0.75$3.0K704,000May 26, 2026May 27, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
4,000——897,395May 26, 2026May 27, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
3,500$0.75$2.6K703,500May 22, 2026May 27, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,500$6.08$21.3K700,000May 22, 2026May 27, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,500——901,395May 22, 2026May 27, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
12,820$0.75$9.6K712,820May 21, 2026May 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
12,820$6.15$78.8K700,000May 21, 2026May 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
12,820——904,895May 21, 2026May 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
9,400——917,715May 20, 2026May 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
9,400$6.15$57.8K700,000May 20, 2026May 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
9,400$0.75$7.0K709,400May 20, 2026May 22, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
9,120——927,115May 19, 2026May 20, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
9,120$0.75$6.8K709,120May 19, 2026May 20, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
9,120$6.37$58.1K700,000May 19, 2026May 20, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
200$6.62$1.3K700,000May 18, 2026May 20, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
200$0.75$150700,200May 18, 2026May 20, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
200——936,235May 18, 2026May 20, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
13,100——936,435May 15, 2026May 18, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
13,100$0.75$9.8K713,100May 15, 2026May 18, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
13,100$6.65$87.1K700,000May 15, 2026May 18, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
15,580——949,535May 14, 2026May 18, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
15,580$6.91$107.7K700,000May 14, 2026May 18, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
15,580$0.75$11.7K715,580May 14, 2026May 18, 2026 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
50,000$0.75$37.5K700,000Apr 1, 2025May 14, 2025 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
50,000——965,115Apr 1, 2025May 14, 2025 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
150,000$0.75$112.5K650,000Mar 27, 2025Apr 25, 2025 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
150,000——1,015,115Mar 27, 2025Apr 25, 2025 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
200,000$0.75$150.0K500,000Mar 26, 2025Apr 25, 2025 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
200,000——1,165,115Mar 26, 2025Apr 25, 2025 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
SALE
Chief Operating Officer
300,000——1,365,115Mar 24, 2025Apr 25, 2025 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
300,000$0.75$225.0K300,000Mar 24, 2025Apr 25, 2025 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
300,000——300,000Mar 7, 2025Mar 11, 2025 ↗View →
GYRE
GYRE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,665,115——1,665,115Nov 20, 2023Nov 22, 2023 ↗View →
Other insiders · GYRE
Loading peer insiders…
About this filer
CIK 0001985496
ROLE
Chief Operating Officer
PRIMARY
GYRE
COMPANIES
1
ACTIVE SINCE
Nov 2023
MARKETPEEL · /INSIDER/0001985496DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback